Concentrix Corporation

NASDAQ:CNXC

40.65 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 2,387.4122,380.7162,402.7482,230.7621,632.8341,614.7061,636.4041,640.7181,579.6021,568.1011,536.0521,466.6081,397.2511,369.8781,353.2781,300.8581,163.6931,066.3621,188.621,212.8361,160.9281,160.8771,173.271
Cost of Revenue 1,523.221,699.5191,730.7331,407.9051,039.1421,034.4811,055.2431,047.3531,012.7541,009.185997.918947.24915.91887.149867.228842.226751.161721.193743.429754.405734.747730.35739.962
Gross Profit 864.192681.197672.015822.857593.692580.225581.161593.365566.848558.916538.134519.368481.341482.729486.05458.632412.532345.169445.191458.431426.181430.527433.309
Gross Profit Ratio 0.3620.2860.280.3690.3640.3590.3550.3620.3590.3560.350.3540.3440.3520.3590.3530.3550.3240.3750.3780.3670.3710.369
Reseach & Development Expenses 00000000000000000000000
General & Administrative Expenses 00000000000000000000000
Selling & Marketing Expenses 00000000000000000000000
SG&A 710.95499.458493.98642.41431.425417.659425.114415.375409.303402.004390.389361.463329.962354.505351.161338.425335.77321.59356.979356.977346.956352.551345.201
Other Expenses 36.63619.4156.824-32.829-6.169-9.383-3.71412.6412.0862.5457.6160.7445.8583.546-3.8033.164-0.5931.6413.235-0.401000
Operating Expenses 710.95499.458493.98642.41431.425417.659425.114415.375409.303402.004390.389361.463329.962354.505351.161338.425335.77321.59356.979356.977353.706367.683373.069
Operating Income 153.242181.739178.035180.447162.267162.56674.898112.22691.19780.85181.268157.905151.379128.224134.889120.20776.76323.5888.211101.45479.22577.97688.108
Operating Income Ratio 0.0640.0760.0740.0810.0990.1010.0460.0680.0580.0520.0530.1080.1080.0940.10.0920.0660.0220.0740.0840.0680.0670.075
Total Other Income Expenses Net -126.826-63.042-75.615-103.337-55.462-56.596-37.704-15.421-8.186-10.428-1.154-2.9860.99-3.199-11.506-5.634-9.595-11.287-14.35-20.627-22.719-23.12-23.45
Income Before Tax 26.41687.12872.82477.11106.805105.97118.343162.569149.359146.484146.591154.919152.369125.025123.383114.57367.16812.29373.86180.82747.30639.14237.141
Income Before Tax Ratio 0.0110.0370.030.0350.0650.0660.0720.0990.0950.0930.0950.1060.1090.0910.0910.0880.0580.0120.0620.0670.0410.0340.032
Income Tax Expense 9.78520.29420.7227.62329.1727.1230.47357.62542.23533.45136.05230.81142.61542.12134.57249.94621.7719.82321.54448.95716.97517.9033.417
Net Income 16.63166.83452.10269.48777.63578.8587.87104.944106.69113.142110.273124.108109.75482.90488.81164.62745.3972.4752.31731.8730.33121.23933.724
Net Income Ratio 0.0070.0280.0220.0310.0480.0490.0540.0640.0680.0720.0720.0850.0790.0610.0660.050.0390.0020.0440.0260.0260.0180.029
EPS 0.250.980.761.11.51.511.692.022.082.192.122.372.11.591.721.250.880.0481.010.620.5880.4120.654
EPS Diluted 0.250.980.761.091.491.511.682.012.072.182.122.352.081.571.691.250.880.0481.010.620.5870.4110.652
EBITDA 283.351358.111362.54985.735259.339248.732241.006-40.503251.731238.034222.27-49.916218.52199.048202.131210.537144.51291.763160.24193.572153.903156.991166.119
EBITDA Ratio 0.1190.1510.1510.1360.0960.0950.0930.1160.1070.1020.1010.1080.1130.0960.0970.0950.1240.0860.1350.1440.1330.1350.142